搜索
C4 Therapeutics Inc
CCCC添加自选
3.480USD
-0.180-4.92%
收盘 07-31 16:00（美东）报价延迟15分钟
384.77M总市值
亏损市盈率 TTM
股东统计
更新时间: 5月10日 周日
更新时间: 5月10日 周日
持股股东
股东类型
持股股东
持股股东
占比
Point72 Asset Management, L.P.
8.54%
Morgan Stanley & Co. LLC
8.10%
RA Capital Management, LP
7.24%
Lynx1 Capital Advisors LLC
6.33%
Vanguard Capital Management, LLC
3.49%
其他
66.30%
持股股东
持股股东
占比
Point72 Asset Management, L.P.
8.54%
Morgan Stanley & Co. LLC
8.10%
RA Capital Management, LP
7.24%
Lynx1 Capital Advisors LLC
6.33%
Vanguard Capital Management, LLC
3.49%
其他
66.30%
股东类型
持股股东
占比
Investment Advisor
24.05%
Hedge Fund
20.77%
Research Firm
12.49%
Venture Capital
7.36%
Investment Advisor/Hedge Fund
6.20%
Individual Investor
1.88%
Private Equity
1.28%
Bank and Trust
0.59%
Pension Fund
0.21%
其他
25.17%
机构持股
更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
296
76.03M
69.01%
-8.78M
2025Q4
294
70.34M
70.90%
+17.39M
2025Q3
308
52.96M
108.83%
-2.15M
2025Q2
306
55.08M
118.23%
-10.19M
2025Q1
320
64.50M
110.39%
-13.86M
2024Q4
320
64.84M
109.43%
+173.51K
2024Q3
315
64.67M
104.71%
+3.40M
2024Q2
309
61.26M
103.56%
+2.76M
2024Q1
313
58.50M
89.36%
-2.80M
2023Q4
309
47.27M
101.07%
+10.16M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Point72 Asset Management, L.P.
9.44M
9.67%
+961.68K
+11.34%
Dec 31, 2025
Morgan Stanley & Co. LLC
8.96M
9.18%
+4.09M
+84.18%
Dec 31, 2025
RA Capital Management, LP
8.00M
8.2%
--
--
Dec 31, 2025
Lynx1 Capital Advisors LLC
7.10M
7.27%
--
--
Dec 31, 2025
Soleus Capital Management, L.P.
3.80M
3.9%
-3.25M
-46.07%
Dec 31, 2025
Bain Capital Life Sciences Investors, LLC
3.13M
3.21%
+1.11M
+55.05%
Dec 31, 2025
Wasatch Global Investors Inc
4.34M
4.45%
-507.82K
-10.46%
Dec 31, 2025
Two Sigma Investments, LP
2.58M
2.64%
+979.98K
+61.33%
Dec 31, 2025
BofA Global Research (US)
2.39M
2.45%
+334.42K
+16.29%
Dec 31, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Micro-Cap ETF
0.03%
Fidelity Enhanced Small Cap ETF
0.02%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
ProShares Ultra Nasdaq Biotechnology
0.02%
Invesco Nasdaq Biotechnology ETF
0.02%
iShares Biotechnology ETF
0.01%
Avantis US Small Cap Equity ETF
0.01%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 Value ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
查看更多
iShares Micro-Cap ETF
占比0.03%
Fidelity Enhanced Small Cap ETF
占比0.02%
Invesco RAFI US 1500 Small-Mid ETF
占比0.02%
ProShares Ultra Nasdaq Biotechnology
占比0.02%
Invesco Nasdaq Biotechnology ETF
占比0.02%
iShares Biotechnology ETF
占比0.01%
Avantis US Small Cap Equity ETF
占比0.01%
ProShares Hedge Replication ETF
占比0%
iShares Russell 2000 Value ETF
占比0%
iShares Core S&P Total U.S. Stock Market ETF
占比0%